Skip to main content
. 2021 Sep 12;12(19):2574–2584. doi: 10.1111/1759-7714.14141

TABLE 2.

Treatment‐related adverse events

Adverse event Grade 1, no. Grade 2, no. Grade 3, no. All grades, %
Rash 5 4 0 37.5
Diarrhea 3 1 2 25.0
Hypertension 0 6 0 25.0
Transaminase elevation 3 1 0 16.7
Fatigue 0 0 4 16.7
Bleeding 0 3 0 12.5
Proteinuria 1 1 0 8.3
Paronychia 0 1 0 4.2
Thrombosis 0 1 0 4.2
Leukopenia 0 1 0 4.2

Note: There were no grade 4/5 adverse events.